Integrium Clinical Research specializes in the strategy, study design, and execution of Phase I-IV clinical trials, with an expertise in Proof of Concept trials.
It has strong clinical trial experience in a range of therapeutic indications including cardiovascular, metabolic, renal, inflammatory, dermatology, regenerative, orphan, and wound healing drug development. Founded in 1998, Integrium has 100+ employees with CRO, PK Unit, and Research Clinic locations in California, New Jersey, and South Africa. It has access to 7,000+ patients within varying disease states and 2,500+ healthy volunteers. It has also CRO partners in Europe, Australia, and India. The PK Unit is equipped with the necessary tools to run your Phase I POC study and the unparalleled Patient Recruitment team will assure your patient enrollment success.
Please contact Randa Wahid for more details: Randa.Wahid@integrium.com